Atai Life Sciences N.V.
ATAI
$1.47
$0.053.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.21% | 54.14% | -114.55% | -46.04% | -141.34% |
| Total Depreciation and Amortization | 171.08% | 1.22% | -1.20% | -17.82% | 36.49% |
| Total Amortization of Deferred Charges | 43.51% | 33.67% | 0.00% | -1.01% | 0.00% |
| Total Other Non-Cash Items | 87.31% | -74.33% | 323.76% | 237.90% | 89.70% |
| Change in Net Operating Assets | -33.12% | -205.24% | 157.44% | -290.14% | 673.31% |
| Cash from Operations | -25.61% | -19.18% | 28.11% | -2.78% | -19.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 200.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.01% | 52.38% | 42.11% | 1,446.36% | 98.15% |
| Cash from Investing | -73.59% | 52.38% | 42.11% | 1,493.80% | 98.23% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 180.00% | -83.13% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -96.85% | 1,401.23% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -48.10% | 259.09% | 203.13% | 69.81% | -166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -264.23% | 2,186.02% | 104.16% | 64.51% | 51.30% |